Saturday 17 October 2026 Export GILD’s income statement to Excel — free account

Gilead Sciences, Inc.

GILD Healthcare Drug Manufacturers General

Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS fell 638.2%, free cash flow grew 376.8% and total debt rose 5.21%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for ten consecutive years.

156.19 1.18 −0.75%

Follow GILD

Alert me

Market cap: $195.1B
P/E: 0.0×
Fwd P/E: −46.2×
Dividend yield: 2.08%
F-score: 8/9
Altman Z: 4.03
Beneish M: −2.45
Dividend safety: 77/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	40.71%	40.66%	43.36%	(20.68%)
Piotroski F-Score Full definition →		8	8	9	5
ROA Full definition →		14.35%	14.42%	16.35%	(6.17%)
ROIC Full definition →		16.79%	15.69%	17.07%	(4.48%)
Return on Tangible Assets Full definition →		73.22%	70.13%	62.26%	(36.99%)
Average Days of Receivables Full definition →		63.93	60.91	58.19	60.58
Free Cash Flow per Share Full definition →		7.37	7.60	8.24	10.41
Free Cash Flow Full definition →		9,162.00	9,456.00	10,230.00	12,943.00
Capital Expenditures Full definition →		(505.00)	(563.00)	(576.00)	(609.00)
Other line items
Cash ROIC Full definition →		17.05%	17.13%	19.21%	31.44%
Accounts Receivable Turnover Full definition →		6.01	6.31	6.51	6.19
Accounts Payable Turnover Full definition →		7.24	8.05	8.88	9.90
Inventory Turnover Full definition →		3.39	3.58	3.34	3.29
Average Days of Payables Full definition →		47.64	41.86	38.35	39.57
Days of Inventory on Hand Full definition →		105.24	103.87	113.80	114.66
Tax Rate Full definition →		(0.18)	(0.13)	(0.14)	0.66
Research and Development Expense of Revenue Full definition →		20.14%	19.70%	19.48%	19.91%
Selling, General and Administrative Expense of Revenue Full definition →		20.24%	19.61%	20.07%	21.42%
Share Based Compensation of Revenue Full definition →		3.05%	3.04%	3.04%	2.98%
Interest Coverage Full definition →		10.30	9.79	10.33	(2.51)
Operating CF/Net income Full definition →		1.19	1.18	1.17	(4.18)
Depreciation/Fixed assets Full definition →		0.50	0.49	0.49	0.47
Capex/Depreciation Full definition →		(0.18)	(0.20)	(0.21)	(0.22)
Revenue per Share Full definition →		23.40	23.67	23.94	24.50
Operating CF per Share Full definition →		7.78	8.05	8.70	10.90
Capex per Share Full definition →		(0.41)	(0.45)	(0.46)	(0.49)
Capex to Sales Full definition →		0.02	0.02	0.02	0.02

Show all line items

Columns are period end dates

Stockrow Weekly